Based on the data from CD226-deficient mice, Gilfillan concluded that CD226 plays an indispensable role in triggering the activation of CD8+ T cells in peripheral tissues, whereas it augments the ability of NK cells to execute cytotoxicity against tumor cells [47, 48]. Here, CD226 is linked to neoplasm.